• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.87% Nasdaq Up 0.34%

    Salix Pharmaceuticals Ltd. (SLXP)

    -NasdaqGS
    117.46 Up 0.26(0.22%) 4:00PM EST
    |After Hours : 117.46 0.00 (0.00%) 4:28PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:117.20
    Open:116.29
    Bid:112.00 x 100
    Ask:117.40 x 500
    1y Target Est:126.56
    Beta:0.87
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:113.00 - 117.94
    52wk Range:86.00 - 172.98
    Volume:1,460,577
    Avg Vol (3m):2,710,000
    Market Cap:7.48B
    P/E (ttm):N/A
    EPS (ttm):-1.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SLXP

    Comparison

    Symbol% ChgMkt Cap
    SLXPUp 0.22%7.48B
    BAYRYUp 1.52%116.97B
    GSKUp 0.21%104.43B
    WCRX 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):30.67
    P/S (ttm):5.42
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :4.09
    Quarterly EPS Est (Dec-14) :-0.10
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback